Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA

King Faisal Specialist Hospital & Research Center

Status and phase: Completed; Phase 3

Conditions: Nasopharyngeal Carcinoma

Treatments: Radiation: Radiation Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT00535795

RAC#0971-004

Details and patient eligibility

About

Phase III: Assess conventional RT w/ conventional Plus accelerated boost RT in the treatment of nasopharyngeal CA

Full description

It's a phase III study to assess conventional Rad Therapy with conventional Plus accelerated boost Rad Therapy in the treatment of nasopharyngeal carcinoma.

Enrollment: 200 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with nasopharyngeal Carcinoma

Exclusion criteria

• Patients with carcinoma other than histo-pathologically confirmed nasopharyngeal CA

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

200 participants in 2 patient groups

1

Active Comparator group

Description:

Conventional Radiation Therapy (XRT), one fraction per day, from Sunday to Thursday every week.

Treatment:

Radiation: Radiation Therapy

2

Experimental group

Description:

Conventional Plus accelerated boost Radiation Therapy (XRT), from Sunday to Thursday every week.

Treatment:

Radiation: Radiation Therapy